Cargando…

Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer’s disease

Plasma biomarkers for Alzheimer’s disease-related pathologies have undergone rapid developments during the past few years, and there are now well-validated blood tests for amyloid and tau pathology, as well as neurodegeneration and astrocytic activation. To define Alzheimer’s disease with biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stevenson-Hoare, Joshua, Heslegrave, Amanda, Leonenko, Ganna, Fathalla, Dina, Bellou, Eftychia, Luckcuck, Lauren, Marshall, Rachel, Sims, Rebecca, Morgan, Bryan Paul, Hardy, John, de Strooper, Bart, Williams, Julie, Zetterberg, Henrik, Escott-Price, Valentina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924904/ https://www.ncbi.nlm.nih.gov/pubmed/35383826 http://dx.doi.org/10.1093/brain/awac128

Ejemplares similares

Genetic risk for alzheimer disease is distinct from genetic risk for amyloid deposition
por: Leonenko, Ganna, et al.
Publicado: (2019)

Identifying individuals with high risk of Alzheimer’s disease using polygenic risk scores
por: Leonenko, Ganna, et al.
Publicado: (2021)

Comparison of long-term effects of metformin on longevity between people with type 2 diabetes and matched non-diabetic controls
por: Stevenson-Hoare, Joshua, et al.
Publicado: (2023)

Polygenic risk and pleiotropy in neurodegenerative diseases
por: Bellou, Eftychia, et al.
Publicado: (2020)

Age-dependent effect of APOE and polygenic component on Alzheimer's disease
por: Bellou, Eftychia, et al.
Publicado: (2020)

Are Alzheimer's and coronary artery diseases genetically related to longevity?
por: Bellou, Eftychia, et al.
Publicado: (2023)

Alzheimer’s disease-associated complement gene variants influence plasma complement protein levels
por: Veteleanu, Aurora, et al.
Publicado: (2023)

Defining functional variants associated with Alzheimer’s disease in the induced immune response
por: Harwood, Janet C, et al.
Publicado: (2021)

Polygenic risk and hazard scores for Alzheimer's disease prediction
por: Leonenko, Ganna, et al.
Publicado: (2019)

Whole genome analysis in APOE4 homozygotes identifies the DAB1-RELN pathway in Alzheimer's disease pathogenesis
por: Bracher-Smith, Matthew, et al.
Publicado: (2022)

Genome-wide association studies for Alzheimer’s disease: bigger is not always better
por: Escott-Price, Valentina, et al.
Publicado: (2022)

Genetic Variants and Related Biomarkers in Sporadic Alzheimer’s Disease
por: Guerreiro, Rita, et al.
Publicado: (2014)

Golgi apparatus, endoplasmic reticulum and mitochondrial function implicated in Alzheimer’s disease through polygenic risk and RNA sequencing
por: Crawford, Karen, et al.
Publicado: (2022)

What does heritability of Alzheimer’s disease represent?
por: Baker, Emily, et al.
Publicado: (2023)

Machine learning for the life-time risk prediction of Alzheimer’s disease: a systematic review
por: Rowe, Thomas W, et al.
Publicado: (2021)

Genetic variability in response to amyloid beta deposition influences Alzheimer’s disease risk
por: Salih, Dervis A, et al.
Publicado: (2019)

Stability of blood-based biomarkers of Alzheimer's disease over multiple freeze-thaw cycles
por: Keshavan, Ashvini, et al.
Publicado: (2018)

Alzheimer’s Disease Biomarkers Revisited From the Amyloid Cascade Hypothesis Standpoint
por: Alawode, Deborah O. T., et al.
Publicado: (2022)

Polygenic Risk Scores in Alzheimer's Disease: Current Applications and Future Directions
por: Baker, Emily, et al.
Publicado: (2020)

Aducanumab: a new phase in therapeutic development for Alzheimer’s disease?
por: Lalli, Giovanna, et al.
Publicado: (2021)

Probability of Alzheimer’s disease based on common and rare genetic variants
por: Escott-Price, Valentina, et al.
Publicado: (2021)

A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene
por: Magusali, Naciye, et al.
Publicado: (2021)

Correction to: Probability of Alzheimer’s disease based on common and rare genetic variants
por: Escott-Price, Valentina, et al.
Publicado: (2021)

Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
por: Heslegrave, Amanda, et al.
Publicado: (2016)

Measuring heritable contributions to Alzheimer’s disease: polygenic risk score analysis with twins
por: Karlsson, Ida K., et al.
Publicado: (2022)

Phenotypic Screening Identifies Modulators of Amyloid Precursor Protein Processing in Human Stem Cell Models of Alzheimer’s Disease
por: Brownjohn, Philip W., et al.
Publicado: (2017)

Polygenic Risk Score Analysis of Alzheimer’s Disease in Cases without APOE4 or APOE2 Alleles
por: Escott-Price, V., et al.
Publicado: (2018)

Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer’s disease
por: Baker, Emily, et al.
Publicado: (2019)

Prion protein in Alzheimer's pathogenesis: a hot and controversial issue
por: Benilova, Iryna, et al.
Publicado: (2010)

From Polygenic Scores to Precision Medicine in Alzheimer’s Disease: A Systematic Review
por: Harrison, Judith R., et al.
Publicado: (2020)

A data‐driven investigation of relationships between bipolar psychotic symptoms and schizophrenia genome‐wide significant genetic loci
por: Leonenko, Ganna, et al.
Publicado: (2018)

Overlapping brain correlates of superior cognition among children at genetic risk for Alzheimer’s disease and/or major depressive disorder
por: Petrican, Raluca, et al.
Publicado: (2023)

CSF pro-orexin and amyloid-β38 expression in Alzheimer's disease and frontotemporal dementia
por: Heywood, Wendy E., et al.
Publicado: (2018)

Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease
por: Sánchez-Valle, Raquel, et al.
Publicado: (2018)

Fluid biomarkers and risk of neurodegenerative disease in retired athletes with multiple concussions: results from the International Concussion and Head Injury Research Foundation Brain health in Retired athletes Study of Ageing and Impact-Related Neurodegenerative Disease (ICHIRF-BRAIN study)
por: Swann, Owen James, et al.
Publicado: (2022)

APP mouse models for Alzheimer's disease preclinical studies
por: Sasaguri, Hiroki, et al.
Publicado: (2017)

Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome
por: Strydom, Andre, et al.
Publicado: (2018)

The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
por: Walgrave, Hannah, et al.
Publicado: (2021)

ADVANCE-TBI study protocol: traumatic brain injury outcomes in UK military personnel serving in Afghanistan between 2003 and 2014 – a longitudinal cohort study
por: Graham, Neil S N, et al.
Publicado: (2023)

Molecular biomarkers of Alzheimer's disease: progress and prospects
por: Lashley, Tammaryn, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jpi6kafamkcccms5bbsh25jvc6